Listen for Questions About Meds to Prevent RSV in Young Children
October 2023
Nirsevimab-alip (Beyfortus) will be a new med to prevent respiratory syncytial virus (RSV) in young children.
You’ll hear nirsevimab called a vaccine...since it’s an intramuscular (IM) injection that provides protection against RSV. But it’s a monoclonal antibody that’s given in a clinic or hospital.
Nirsevimab joins palivizumab (Synagis)...another injectable monoclonal antibody to prevent serious illness from RSV.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote